Magnetic-Manipulated NK Cell Proliferation and Activation Enhance Immunotherapy of Orthotopic Liver Cancer

Amelioration of systemic antitumor immune responses in cocktail therapy by immunomodulatory nanozymes

(2022) Shuren Wang et al.   Science Advances

Catalytical nano-immunocomplexes for remote-controlled sono-metabolic checkpoint trimodal cancer therapy

(2022) Chi Zhang et al.   Nature Communications

Checkpoint Nano‐PROTACs for Activatable Cancer Photo‐Immunotherapy

(2022) Chi Zhang et al.   ADVANCED MATERIALS

Nanoparticles with ultrasound-induced afterglow luminescence for tumour-specific theranostics

(2022) Cheng Xu et al.   Nature Biomedical Engineering

Triformyl cholic acid and folic acid functionalized magnetic graphene oxide nanocomposites: Multiple-targeted dual-modal synergistic chemotherapy/photothermal therapy for liver cancer

(2021) Tao Gong et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Receptor-gated IL-2 delivery by an anti-human IL-2 antibody activates regulatory T cells in three different species

(2020) Ufuk Karakus et al.   Science Translational Medicine

Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies

(2019) Yahya Ashraf et al.   Journal for ImmunoTherapy of Cancer

Combined strategies for tumor immunotherapy with nanoparticles

(2019) K. Savitsky et al.   Clinical & Translational Oncology

Acid-induced degradation of widely used NIR dye DiR causes hypsochromic shift in fluorescence properties

(2019) Markus Riehl et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

In vivo molecular imaging for immunotherapy using ultra-bright near-infrared-IIb rare-earth nanoparticles

(2019) Yeteng Zhong et al.   NATURE BIOTECHNOLOGY

Human HSP70 Promoter-Based Prussian Blue Nanotheranostics for Thermo-Controlled Gene Therapy and Synergistic Photothermal Ablation

(2018) Yajuan Liu et al.   ADVANCED FUNCTIONAL MATERIALS

Hepatocellular carcinoma: Prospects for natural killer cell immunotherapy

(2018) N. Kumar et al.   HLA

Lack of FcRn Impairs Natural Killer Cell Development and Functions in the Tumor Microenvironment

(2018) Diana Cadena Castaneda et al.   Frontiers in Immunology

In silico modeling identifies CD45 as a regulator of IL-2 synergy in the NKG2D-mediated activation of immature human NK cells

(2017) Sayak Mukherjee et al.   Science Signaling

In silico modeling identifies CD45 as a regulator of IL-2 synergy in the NKG2D-mediated activation of immature human NK cells

(2017) Sayak Mukherjee et al.   Science Signaling

Release of Doxorubicin by a Folate-Grafted, Chitosan-Coated Magnetic Nanoparticle

(2017) Chung-Lin Yang et al.   Nanomaterials

Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure)

(2016) J. M. Kim et al.   ANNALS OF ONCOLOGY

Chimeric antigen receptor T cell therapy: 25years in the making

(2016) Saar Gill et al.   BLOOD REVIEWS

Immune targets and neoantigens for cancer immunotherapy and precision medicine

(2016) Rong-Fu Wang et al.   CELL RESEARCH

The future of cancer treatment: immunomodulation, CARs and combination immunotherapy

(2016) Danny N. Khalil et al.   Nature Reviews Clinical Oncology

NLRC5/MHC class I transactivator is a target for immune evasion in cancer

(2016) Sayuri Yoshihama et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Status of and prospects for cancer vaccines against hepatocellular carcinoma in clinical trials

(2016) Zhipeng Sun et al.   BioScience Trends

Immune Checkpoint Blockade in Cancer Therapy

(2015) Michael A. Postow et al.   JOURNAL OF CLINICAL ONCOLOGY

Immunological landscape and immunotherapy of hepatocellular carcinoma

(2015) Jesús Prieto et al.   Nature Reviews Gastroenterology & Hepatology

T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition

(2015) R. Houot et al.   Cancer Immunology Research

Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF- 1

(2014) H. Li et al.   JOURNAL OF IMMUNOLOGY

IL-2: The First Effective Immunotherapy for Human Cancer

(2014) S. A. Rosenberg   JOURNAL OF IMMUNOLOGY

Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma

(2014) Amir Shlomai et al.   SEMINARS IN CANCER BIOLOGY

High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014

(2014) Janice P Dutcher et al.   Journal for ImmunoTherapy of Cancer

The HSP70 family and cancer

(2013) M. E. Murphy   CARCINOGENESIS

Ex vivo activation and expansion of natural killer cells from patients with advanced cancer with feeder cells from healthy volunteers

(2013) Eun-Kyung Kim et al.   CYTOTHERAPY

Oncology Meets Immunology: The Cancer-Immunity Cycle

(2013) Daniel S. Chen et al.   IMMUNITY

Physical limits of pure superparamagnetic Fe3O4 nanoparticles for a local hyperthermia agent in nanomedicine

(2012) Minhong Jeun et al.   APPLIED PHYSICS LETTERS

Clinical-Scale Isolation of Interleukin-2-Stimulated Liver Natural Killer Cells for Treatment of Liver Transplantation with Hepatocellular Carcinoma

(2012) Masahiro Ohira et al.   CELL TRANSPLANTATION

Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions

(2012) Yan Wu et al.   HEPATOLOGY

Critical Role of STAT5 Transcription Factor Tetramerization for Cytokine Responses and Normal Immune Function

(2012) Jian-Xin Lin et al.   IMMUNITY

Study of Heating Efficiency as a Function of Concentration, Size, and Applied Field in γ-Fe2O3 Nanoparticles

(2012) P. de la Presa et al.   Journal of Physical Chemistry C

Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrence

(2011) Hiroteru Kamimura et al.   JOURNAL OF HEPATOLOGY

Functions of natural killer cells

(2008) Eric Vivier et al.   NATURE IMMUNOLOGY